Business
Citing tax reasons, Bill Ackman, the activist investor and a strong defender of Valeant Pharmaceuticals International, has reduced his firm’s stake in...
Hi, what are you looking for?
Citing tax reasons, Bill Ackman, the activist investor and a strong defender of Valeant Pharmaceuticals International, has reduced his firm’s stake in...
The FTC has been investigating Valeant for potentially cornering a portion of the lens market.
A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them...
From 2010, Valeant shares rose more than 10-fold to peak in August. Unfortunately, from a systemic perspective, just about every American is worse...
Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman...
Besides climbing to the top of the hedge fund world, activist investor Bill Ackman has become one of the most successful hedge fund managers...
Bill Ackman might be controversial, but he had the top performing hedge fund of 2014, as reported by Bloomberg. While he was ridiculed the...
Bill Ackman has cleaned up this year to the tune of $1 billion. He has also profited from Actavis’ announced merger with Botox maker...
– Valeant Pharmaceuticals International Inc is abandoning its growth-by-acquisitions strategy for the time being to try to reduce debt, boost its stock price and...
The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical...